congenital hyperinsulinism therapeutic (Xinvento)

N/A

Report date: 2025/03/20 09:19:48
NME

Base Information

Drug Namecongenital hyperinsulinism therapeutic (Xinvento)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperinsulinism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXinvento BV
China Registration ClassN/A

Develop Information

Active CompaniesXinvento BV
Inactive CompaniesN/A
Active IndicationsHyperinsulinism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A